R. V. van Soest

Detection and Functional Analysis of CD8+ T Cells Specific for PRAME: a Target for T-Cell Therapy

S. H. van der Burg, C. Melief, J. Falkenburg, 2006, Clinical Cancer Research.

Translating sanger-based routine DNA diagnostics into generic massive parallel ion semiconductor sequencing.

M. Nelen, H. Scheffer, K. Neveling, 2015, Clinical chemistry.

Sublocalization of the breakpoints of a t(5;16) in myelodysplasia.

A. V. van Kessel, R. Willemze, B. Janssen, 1998, Cancer genetics and cytogenetics.

Is the $1000 Genome as Near as We Think? A Cost Analysis of Next-Generation Sequencing.

Gert Jan van der Wilt, Janneke P C Grutters, J. Veltman, 2016, Clinical chemistry.

Prognostic relevance of occult tumour cells in lymph nodes in colorectal cancer.

H. Tanke, R. Tollenaar, P. Kuppen, 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Up-regulated expression in nonhematopoietic tissues of the BCL2A1-derived minor histocompatibility antigens in response to inflammatory cytokines: relevance for allogeneic immunotherapy of leukemia.

J. Falkenburg, R. Willemze, F. Kloosterboer, 2005, Blood.

The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease.

J. Drijfhout, M. Kester, R. Willemze, 2002, Blood.

A DNA probe combination for improved detection of MLL/11q23 breakpoints by double‐color interphase‐FISH in acute leukemias

A. Hagemeijer, E. Schuuring, M. Stul, 2000, Genes, chromosomes & cancer.

Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.

W. M. Smit, J. Falkenburg, R. Willemze, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

α-Interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease

W. M. Smit, J. Falkenburg, R. Willemze, 2004 .